A share price of Inspire Medical Systems Inc [INSP] is currently trading at $211.52, up 7.44%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INSP shares have gain 17.63% over the last week, with a monthly amount glided 12.68%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on May 08, 2024, when BofA Securities downgraded its rating to a Neutral and also revised its price target to $225 from $265. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on April 19, 2024, and set its price target to $285. On March 19, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $250 on the stock. Jefferies initiated its recommendation with a Buy and recommended $245 as its price target on January 19, 2024. Stifel downgraded its rating to Hold for this stock on January 02, 2024, but kept the price target unchanged to $210. In a note dated December 13, 2023, Wells Fargo downgraded an Equal Weight rating on this stock and revised its target price from $245 to $187.
Inspire Medical Systems Inc experienced fluctuations in its stock price throughout the past year between $123.00 and $257.40. Currently, Wall Street analysts expect the stock to reach $237.8 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $211.52 at the most recent close of the market. An investor can expect a potential return of 12.42% based on the average INSP price forecast.
Analyzing the INSP fundamentals
Trailing Twelve Months sales for Inspire Medical Systems Inc [NYSE:INSP] were 705.71M which represents 29.65% growth. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.01 and Total Capital is -0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 205.61 points at the first support level, and at 199.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 221.21, and for the 2nd resistance point, it is at 230.91.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Inspire Medical Systems Inc [NYSE:INSP] is 9.25. Also, the Quick Ratio is 8.35, while the Cash Ratio stands at 2.86. Considering the valuation of this stock, the price to sales ratio is 8.94, the price to book ratio is 9.88 and price to earnings (TTM) ratio is 1164.12.
Transactions by insiders
Recent insider trading involved SHAWN T MCCORMICK, Director, that happened on Sep 09 ’24 when 800.0 shares were purchased. Officer, JOHN RONDONI completed a deal on Sep 09 ’24 to buy 31.0 shares. Meanwhile, Chief Technology Officer Rondoni John sold 5000.0 shares on Aug 22 ’24.
